Oncology & Cancer

Testosterone therapy does not up prostate cancer incidence

(HealthDay) -- Testosterone replacement therapy (TRT) appears to be safe and does not increase the incidence of prostate cancer, according to a study published online June 6 in The Journal of Sexual Medicine.

Oncology & Cancer

Active surveillance cost-effective for prostate cancer

(HealthDay) -- In a theoretical cohort of 120,000 men, selecting active surveillance for prostate cancer results in considerable cost savings at five and 10 years of follow-up, compared with immediate treatment, according ...

Oncology & Cancer

Life expectancy prolonged for esophageal cancer patients

For those with esophageal cancer, initial staging of the disease is of particular importance as it determines whether to opt for a curative treatment or palliative treatment. Research presented in the June issue of The Journal ...

page 1 from 5